Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibitor of human liver glycogen phosphorylase (IC50 = 53 nM).1 It blocks glucagon-induced hepatic glycogenolysis in vivo.1 Glycogen phosphorylase inhibitor has been used to study glycogen utilization in human liver HepG2 cells, retinal explants, and human T lymphocyte Kit 225 cells.2,3,4
WARNING This product is not for human or veterinary use.
1. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. J. Med. Chem. 48(20), 6178-6193 (2005).
2. A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori’s disease. Genes Dev. 21(19), 2399-2409 (2007).
3. Metabolic differentiation in retinal cells. Nat. Cell Biol. 14(8), 859-864 (2012).
4. Rac1 protein regulates glycogen phosphorylase activation and controls interleukin (IL)-